School of Medicine
Showing 201-300 of 12,928 Results
-
Ahmad Al-Moujahed, MD, PhD, MPH
Assistant Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Ahmad Al-Moujahed is a board-certified, fellowship-trained ophthalmologist with Stanford Health Care. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Al-Moujahed specializes in caring for retinal and macular diseases, as well as inherited retinal degenerations (IRDs), a group of genetic diseases that cause vision loss. He also specializes in vitreoretinal surgery to treat a range of diseases that affect vision. He is one of the only ophthalmologists in the nation with dedicated vitreoretinal surgery and IRD training and expertise. He is committed to providing compassionate care that improves eye health, vision, and quality of life.
As a physician-scientist, Dr. Al-Moujahed’s research focuses on investigating the origins of IRDs and developing novel treatments for these conditions. He is also involved in clinical trials exploring innovative experimental treatments for IRDs.
He is also deeply interested in the intersection of ophthalmology, public health, and global health. He has contributed to the development of educational programs for medical students and vision care initiatives in Syria and Lebanon, with the goal of expanding access to eye care in underserved communities.
Dr. Al-Moujahed has published his research in peer-reviewed journals, including Investigative Ophthalmology & Visual Science, Experimental Eye Research, Stem Cell Research, Scientific Reports, and American Journal of Ophthalmology. He has also published in Ophthalmology Retina; British Journal of Ophthalmology; European Journal of Ophthalmology; Ophthalmic Surgery, Lasers and Imaging Retina; and the International Journal of Retina and Vitreous.
He has also presented at several national conferences, including meetings of the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, American Academy of Ophthalmology, and Retina Society.
Dr. Al-Moujahed is a member of the American Society of Retina Specialists, American Academy of Ophthalmology, and Association for Research in Vision and Ophthalmology. He is also a member of the Syrian American Medical Society and serves on its Education and Ophthalmology Committee. -
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, Clinical Translation, Graft versus Host Disease, Spatial Biology, Immune-Theragnostics
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation with the motivation of developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response, that are being evaluated in oncology trials around the world. She is currently leading the IND-enabling studies for a first in class PET tracer for T cell activation and has also supported several biomarker detection platforms for early disease detection. She was elected as Co-Chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Key funding: (grant conceptualization/scientific lead): NIH/NCI R01, Pfizer Inc., SNMMI Education and Research Foundation
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
Todd Alamin, MD, FAAOS
Professor of Orthopaedic Surgery
BioDr. Alamin is a board-certified, fellowship-trained orthopaedic surgeon and spine surgeon at Stanford Health Care Orthopaedics and Sports Medicine. He is director of the Spine Surgery Fellowship Program and the Minimally Invasive Spine Center and a professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine. Dr. Alamin completed his spine care and surgery fellowship training at Stanford University School of Medicine/St. Mary’s Medical Center.
Dr. Alamin specializes in advanced, minimally invasive treatments for a range of conditions affecting the spine. He is skilled at relieving pain that results from spinal stenosis, scoliosis, degenerative disc disease, arthritis, and traumatic injuries. He combines extensive expertise with decades of experience to deliver innovative, personalized care to each of his patients.
Dr. Alamin’s research interests include effective treatments for vertebral fractures, spinal deformities, scoliosis, herniated discs, and spondylolisthesis (when a vertebra slides out of place). As principal investigator for multiple clinical trials and research studies, Dr. Alamin has explored nerve ablation as a treatment for chronic low back pain and motion-preserving lumbar fusion techniques. He uses state-of-the-art medical devices, implants, and technology to make spine surgery more effective and help his patients move without pain.
Dr. Alamin is known around the world for the treatment of spine disorders and injuries. He has published more than 65 articles in numerous peer-reviewed journals, including Spine, The Spine Journal, Clinical Spine Surgery, International Journal of Spine Surgery, and Journal of Orthopaedic Research. He has also written several book chapters that focus on diagnosing and treating spine conditions.
A recognized leader in innovative spine surgery techniques, Dr. Alamin has invented dozens of medical devices, methods, and techniques for spine surgery. He holds a number of patents for his inventions, many of which have revolutionized back pain treatments. Physicians around the globe use his techniques and devices to help their patients with spine conditions.
Dr. Alamin has been invited to present at conferences around the globe about spinal fusion procedures, novel techniques to treat spinal stenosis, and the latest medical devices to treat degenerative spondylolisthesis. He has lectured at annual meetings for the Association of Bone and Joint Surgeons, the North American Spine Society, and the International Society for the Study of the Lumbar Spine.
Dr. Alamin is a fellow of the American Academy of Orthopaedic Surgeons. He is a member of the North American Spine Society, the International Society for the Study of the Lumbar Spine, the Spine Arthroplasty Society, and the Society for Minimally Invasive Spine Surgery. -
Fernando Alarid-Escudero
Assistant Professor of Health Policy
BioFernando Alarid-Escudero, Ph.D., is an Assistant Professor of Health Policy at Stanford University School of Medicine. He obtained his Ph.D. in Health Decision Sciences from the University of Minnesota School of Public Health. His research focuses on developing statistical and decision-analytic models to identify optimal prevention, control, and treatment policies and conducting cost-effectiveness analyses to address a wide range of public health problems. He has also developed novel methods to quantify the value of future research. Dr. Alarid-Escudero is a member of three cancers (colorectal [CRC], bladder, and gastric) of the Cancer Intervention and Surveillance Modeling Network (CISNET) consortium, a group of investigators sponsored by the National Cancer Institute in the U.S. that uses simulation modeling to evaluate the impact of cancer control interventions (e.g., prevention, screening, and treatment) on population trends in incidence and mortality. Dr. Alarid-Escudero co-founded the Decision Analysis in R for Technologies in Health (DARTH) workgroup (http://darthworkgroup.com) and the Collaborative Network on Value of Information (ConVOI; https://www.convoi-group.org), international and multi-institutional collaborative efforts that develop transparent and open-source solutions to implement decision analysis and quantify the value of potential future investigation for health policy analysis. He received a BSc in Biomedical Engineering from the Metropolitan Autonomous University in Iztapalapa (UAM-I), and a Master’s in Economics from CIDE, both in Mexico.
-
Alexandriah Nicole Alas, MD
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Alas is a board-certified, fellowship-trained urogynecologist with Stanford Health Care Obstetrics & Gynecology. She is also a pelvic surgeon and a Clinical Associate Professor in the Department of Obstetrics & Gynecology at Stanford University School of Medicine. She specializes in minimally invasive urogynecology and reconstructive pelvic surgery, including vaginal, laparoscopic, robotic and VNOTES approaches.
Dr. Alas has expertise in treating pelvic organ prolapse, urinary and fecal incontinence, bladder pain, vaginal fistulas, mesh and non-mesh procedures as well as treating complications. In addition, she offers uterine preservation surgeries as well as non-surgical options. She is trained in a variety of in-office procedures, including urodynamics, office cystoscopy, bladder Botox injections, urethral injections, PTNS, and sacral neuromodulation tests.
Dr. Alas is nationally recognized for her expertise and serves as a national oral board examiner for the American College of Obstetrics and Gynecology. She is passionate about teaching and has served as the associate fellowship director in Urogynecology in the past and currently supervises, teaches, and mentors medical students, residents, and fellows in urogynecology.
Dr. Alas is actively involved in research and serves on the Society of Gynecological Surgeons Systematic Review Group. She has published her work in many peer-reviewed journals, including International Urogynecology Journal, Journal of Urology, and Obstetrics & Gynecology. She also serves as a reviewer for several peer-reviewed journals and has presented her research nationally and internationally. -
Arash Alavi
Software Engineering Director, Genetics
Current Role at StanfordSoftware Engineering Director
-
Gregory W. Albers, MD
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsOur group's research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.
-
Deborah Alcorn, MD
Associate Professor of Ophthalmology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsGene linkage - tuberous sclerosis; stabismus and, molteno implants; congenital stationary night blindness
-
Alawab Aldulimy
Contingent Employee, CV Med - Clinical Trials
Current Role at StanfordClinical Researcher
Clinical Research Coordinator -
William Alegria
Lecturer, Medicine - Med/Infectious Diseases
BioDr. Alegria is a board-certified Infectious Diseases Pharmacotherapy specialist and antimicrobial stewardship consultant with the Stanford Antimicrobial Safety and Sustainability Program. He primarily practices in the inpatient setting and is dedicated to developing targeted stewardship interventions in immunocompromised patient populations. His clinical interests include management of infections in immunocompromised hosts, antifungal pharmacotherapy, and difficult-to-treat infections.
Publications (selected)
Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Arya R, Zimmet AN, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians. Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN.
Antimicrob Steward Healthc Epidemiol. 2025
Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients. Prasad R, Lu B, Veloria D, Mui E, Nelson J, Dhillon G, Deresinski S, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
No "One-Size-Fits All": chronic "Carryover" diagnoses dilute antibiotic prescribing rates for sinusitis among adults in primary and urgent care settings. Smith M, Hawkins M, Laikijrung C, Mui E, Alegria W, Leung T, Zimmet A, Ha D, Holubar M. Infect Control Hosp Epidemiol. 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Lu B, Ha D, Shen S, Ferguson Toll J, Kim A, Kim S, Mui E, Deresinski S, Holubar M, Alegria W. Open Forum Infect Dis. 2024
"Electronic Phenotyping" Antimicrobials to Facilitate Outpatient Stewardship for Asymptomatic Bacteriuria and Urinary Tract Infection in Renal Transplant. Zimmet AN, Ha D, Mui E, Smith M, Hawkins M, Alegria W, Holubar M. Open Forum Infect Dis. 2024
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. Fox E, Ha D, Bounthavong M, Meng L, Mui E, Holubar M, Deresinski S, Alegria W. BMC Infect Dis. 2022
Shorter durations of antibiotic therapy in organ transplant. Alegria W, Medvedeva N, Holubar M. Curr Opin Organ Transplant. 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. Br J Haematol. 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia. Alegria W, Marini BL, Gregg KS, Bixby DL, Perissinotti A, Nagel J. J Natl Compr Canc Netw. 2022
Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit. Diep C, Meng L, Pourali S, Hitchcock MM, Alegria W, Swayngim R, Ran R, Banaei N, Deresinski S, Holubar M. Am J Health Syst Pharm. 2021 Dec
The Current State of Antifungal Stewardship in Immunocompromised Populations. Alegria W, Patel PK. J Fungi (Basel). 2021
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Holubar M, Meng L, Alegria W, Deresinski S. Infect Dis Clin North Am. 2020
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. Hogan CA, Ebunji B, Watz N, Kapphahn K, Rigdon J, Mui E, Meng L, Alegria W, Holubar M, Deresinski S, Banaei N. J Clin Microbiol. 2020
Antimicrobial Stewardship in Cancer Patients: The Time is Now. Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto JN, Dadwal S, Freifeld AG, Jain R, Pergam SA, Tverdek FP, Seo SK; Antimicrobial Stewardship in Cancer Consortium ASCC. J Natl Compr Canc Netw. 2019 -
Maria Alexandrovna Aleshin, MD
Clinical Associate Professor, Dermatology
BioMaria Aleshin, M.D., is Clinical Associate Professor of Dermatology, Director of the Hidradenitis Suppurativa Clinic, and Co-Director of the Inpatient Dermatology Consult Service at Stanford Medicine. Her clinical interests include hidradenitis suppurativa, complex medical dermatology, and inpatient dermatology. Dr. Aleshin received her B.A. from the University of California, Berkeley and her M.D. from the David Geffen School of Medicine at UCLA. She completed her dermatology residency at UCLA, where she also served as Chief Resident in her final year.
-
Dr. Lydia Aletraris
Social Science Research Scholar, Health Policy
BioDr. Lydia Aletraris brings both a national and global perspective to her research, specializing in substance use and human trafficking. With extensive experience managing projects funded by agencies such as the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, the U.S. Department of Justice, and the U.S. Department of State, she has served as Principal Investigator or Co-Principal Investigator on national research examining the implementation of evidence-based practices in substance use treatment and the effects of U.S. cannabis policy, as well as on international research focused on human trafficking.
Dr. Aletraris previously coordinated the Prevalence Reduction Innovation Forum (PRIF), a global initiative that developed key trafficking indicators and brought together scholars from around the world to test methodologies for measuring human trafficking prevalence, with studies conducted in Brazil, Costa Rica, Morocco, Pakistan, Tanzania, and Tunisia.
With a commitment to health and human rights, her research addresses urgent public health challenges through ethical, evidence-based practices and policies that support resilience and recovery across diverse, at-risk populations. Dr. Aletraris holds a PhD in Sociology from the University of Georgia. -
Amy Alexander
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCollege Mental Health, Emotional Support Animals & Service Animals, Women's Health, Mental Health & Well-being in Veterinarians
-
Kevin M. Alexander, MD, FACC, FHFSA
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Alexander is an advanced heart failure-trained cardiologist. He is also an Assistant Professor of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Alexander specializes in the management of advanced heart failure and transplant cases, seeing a wide range of patients. He also has an active research laboratory, studying various forms of heart failure.
Dr. Alexander has expertise in diagnosing and treating transthyretin cardiac amyloidosis, a critical yet underdiagnosed cause of heart failure among African Americans and the elderly. He is conducting extensive research to enhance our understanding of this condition, with grant support from the National Institutes of Health and American Heart Association, among other sources. -
Steven R. Alexander, MD
Professor of Pediatrics (Nephrology), Emeritus
Current Research and Scholarly InterestsDialysis, kidney transplantation, continuous renal replacement therapy in pediatric patients; chronic kidney disease in pediatric patients.
-
Haider Ali
Postdoctoral Scholar, Ophthalmology
BioHaider Ali, M.B., B.S. is a Postdoctoral Scholar in the Department of Ophthalmology at Stanford University School of Medicine. With over six years of experience in translational research, his work focuses on advancing innovations in retinal imaging, artificial intelligence, and digital health. He is particularly interested in developing technologies that bridge clinical innovation and real-world impact to improve vision care globally.
-
Tayyeba K. Ali, MD
Adjunct Clinical Associate Professor, Ophthalmology
BioTayyeba K. Ali, MD, a Board Certified ophthalmologist, specializes in complex corneal disease and uveitis. She sees patients at Palo Alto Medical Foundation / Sutter Health in Sunnyvale, CA. Dr. Ali also works as a medical specialist on contract for Google.
Prior to completing two fellowships in cornea, external disease, refractive surgery and uveitis at Bascom Palmer Eye Institute, ranked #1 eye hospital in the United States by U.S. News & World Report, Dr. Ali finished her ophthalmology residency at the Jones Eye Institute / UAMS. She earned her medical degree from Emory University School of Medicine and completed her undergraduate training in English literature and creative writing from Agnes Scott College.
Dr. Ali has received many academic and teaching awards including the Bascom Palmer Fellow of the Year Award and the Jone’s Eye Dean’s Faculty Award. She has delivered dozens of lectures on the national and international level and published numerous meeting abstracts and peer-reviewed journal articles.
As a second generation American, Tayyeba finds herself dwelling on migrant and refugee stories, their need for ethnic and religious identity, and the repercussions of these journeys. She is keenly interested in international medicine, resident education, health technology and taking a closer look at the moral crossroads we face in healthcare. She is the Associated Director for Pegasus Physician Writers at Stanford as well as the Senior Fiction Editor for the medical literary magazine, The Pegasus Review; she has a particular affinity for colons (grammatically, not anatomically, speaking) and semicolons. -
Roozbeh Aliabadi
Affiliate, Center for Compassion and Altruism Research and Education
BioDirector of Compassion in AI
Dr. Roozbeh Aliabadi, Ph.D., is an entrepreneur, a global thought leader in AI education, an author, and an advocate for ensuring artificial intelligence serves humanity with ethics, empathy, and compassion.
Dr. Aliabadi is the co-founder and CEO of ReadyAI.org, an organization dedicated to bringing AI education to students in over 150 countries. He is also the co-founder of the World Artificial Intelligence Competition for Youth (WAICY), a global initiative that empowers young minds to solve real-world challenges through AI, fostering creativity, critical thinking, and ethical leadership.
As an author, Dr. Aliabadi has written extensively on AI’s role in education, including books for educators, parents, and children. His latest work, “Intro to AI for Parents (Pocketbook): A Guide to Sparking Fun and Meaningful Conversations with Your Kids about Artificial Intelligence,” helps families engage in meaningful discussions about AI and its impact. His insights on AI and global affairs have been featured in BBC, The Hill, Wall Street Journal, NIKKEI Asian Review, and USA Today.
Dr. Aliabadi has delivered keynote addresses at major global conferences, including Web Summit, AI Global Summit, Global Silicon Valley Forum, and the Aspen Forum. His talks explore AI ethics, education, and the future of compassionate AI, bridging the gap between cutting-edge technology and human-centered values.
His research focuses on the intersection of AI, education, and human-centered technology, particularly emphasizing how AI can enhance social-emotional learning, foster inclusivity in education, and support global digital equity.
Dr. Aliabadi earned a Ph.D. from Robert Morris University, focusing on AI interventions in education, a Master’s degree in International Political Economy, and a Bachelor’s in Finance and Economics from the University of Pittsburgh. With eight years of service in the U.S. Army Joint Special Operations Command (JSOC), he brings a global perspective to the ethical considerations of AI. His expertise in human psychology, education, and geopolitics makes him a leading advocate for AI that empowers and uplifts humanity. -
Leonardo Aliaga
Clinical Assistant Professor, Emergency Medicine
BioDr. Leonardo Aliaga is a Clinical Assistant Professor of Emergency Medicine at Stanford University and a medical education researcher. His scholarly focus lies in error-based learning strategies, adaptive expertise, and clinical reasoning. He is co-Principal Investigator of an AI-powered virtual patient simulator designed to accelerate diagnostic skill development through purposeful exposure to cognitive struggle and contrasting cases that sharpen pattern recognition. He has been invited to give international presentations and to lead an international symposium on error-based learning strategies. His research has been published in JAMA Network Open and focuses on designing instructional methods that harness errors as cognitive catalysts to deepen learning and develop adaptive expertise.
Dr. Aliaga is currently pursuing a Master of Health Professions Education at the University of Illinois at Chicago, where his thesis aims to establish a framework to help educators implement error-based learning strategies across diverse medical education settings. He collaborates with colleagues at UC Davis, Wake Forest University, the University of Toronto, the University of Washington, and University Hospital Basel, and is building the FERN: the Failure in Education Research Network.
Dr. Aliaga brings a unique background to his work, having trained in neurosurgery before transitioning to emergency medicine. That experience shaped how he thinks about expertise and the role of struggle in becoming a truly excellent physician. He also draws from his earlier career in fine arts and photography to shape his approach to teaching—grounded in visual clarity, storytelling, and helping learners “see” through the layers of clinical complexity. He’s known for delivering gritty, high-yield, and visually rich learning experiences that don’t steal the struggle but instead help residents turn missteps into mastery. -
Daniel Aliseda Jover
Clinical Instructor, Surgery - General Surgery
BioDr. Daniel Aliseda graduated in Medicine from the University of Navarra in Pamplona, Spain, and completed his residency in General Surgery at the Clínica Universidad de Navarra. During this time, he developed a strong interest in Hepatobiliopancreatic diseases and Liver Transplantation, which led him to pursue a PhD with international distinction. His research focused on developing models and strategies to improve survival in patients with liver and pancreatic neoplasm—one of which was nationally recognized as the best research project conducted by a surgical resident in Spain. As part of his academic training, he also completed a clinical and research stay at the Centre Hépato-Biliaire Paul Brousse in Paris. After finishing his residency, he joined the HPB and Liver Transplant Unit at the Clínica Universidad de Navarra as a Junior Attending Surgeon.
-
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Current Research and Scholarly InterestsMy research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials. -
Matthew S Alkaitis, MD PhD
Clinical Assistant Professor, Medicine
BioMatthew S Alkaitis MD, PhD is a Clinical Assistant Professor in the Division of Hospital medicine and Stanford School of Medicine. He received his PhD in biochemistry from the University of Oxford, in collaboration the National Institutes of Health as part of the NIH’s graduate partnership program. He received his MD from Harvard Medical school and completed his residency in internal medicine at Stanford. Dr. Alkaitis’ research interests span basic biochemistry, clinical informatics, natural language processing, genetics of hematologic malignancies and methods of cell-free DNA detection. His primary medical education interest is expanding accessibility of modern computational and bioinformatics techniques for clinical research.
-
Jessica M. Allan
Adjunct Clinical Associate Professor, Pediatrics
BioDr. Jessie Allan, MD works as a Pediatric Hospitalist for Palo Alto Medical Foundation. She cares for patients in the Newborn Nursery, Intermediate Care Nursery, and on the inpatient wards at Stanford Children's Hospital. She serves as the chair-elect of the American Academy of Pediatrics, Section on Hospital Medicine.
-
Thea Allen
Director, Resource Management, School of Medicine - Lane Medical Library
Current Role at StanfordDirector of Resource Management, Lane Medical Library
-
Kimberly Allison
Professor of Pathology
Current Research and Scholarly InterestsDr. Allisons clinical expertise is in breast pathology. Her research interests include how standards should be applied to breast cancer diagnostics (such as ER and HER2 testing), the utility of molecular panel-based testing in breast cancer, digital pathology applications and identifying the most appropriate management of specific pathologic diagnoses.
-
Christopher Almond
Professor of Pediatrics (Cardiology)
BioChristopher Almond, MD, MPH is Professor of Pediatrics in the Division of Cardiology at the Stanford University School of Medicine where he is a board-certified pediatric cardiologist at Stanford's Lucile Packard Children's Hospital in Palo Alto, CA. His clinical and research interests are focused on pediatric heart failure, mechanical circulatory support, and heart transplantation. He completed his training in pediatrics, cardiology, and a senior fellowship in heart failure/transplant at Boston Children's Hospital before before appointment as Assistant Professor of Pediatrics at Harvard Medical School/Boston Children’s Hospital. Dr. Almond completed his MPH at the Harvard School of Public Health with a focus on statistics and epidemiology (study design for rare diseases) followed by a Medical Device Fellowship at the FDA in the Division of Cardiovascular Devices at the Center for Devices. Dr. Almond moved to Stanford in 2014 where he currently serves as professor of pediatrics and directs the clinical research program within Pediatric Advanced Cardiac Therapies (PACT) Program. He also serves as Medical Director of the Children’s Heart Center Anticoagulation Management Program at Stanford (CHAMPS). Dr. Almond has a passion for collaborative research serving as PI for federally-funded multicenter clinical trials including the Berlin Heart ventricular assist device (VAD) FDA Trial, the TEAMMATE (everolimus for heart transplant) Trial, the TROLLEY (Cardiohelp ECMO/anticoagulation RCT in heart failure) Trial, the NHLBI PumpKIN (Jarvik 2015 LVAD) Trial, and the SPOT BIAS Trial, an FDA-funded trial to understand racial/pigment bias in commercial pulse oximeters.
-
Faith Aloboudi
Ph.D. Student in Neurosciences, admitted Autumn 2024
BioI am a second-year Ph.D. Neurosciences IDP Student co-mentored by Dr. Anish Mitra and Dr. Lisa Giocomo elucidating cognitive function in mesoscale cortical networks. I’m also interested in how biopsychosocial factors, like social determinants of health, impact neuropsychiatric disorders.
-
Leina Alrabadi
Clinical Associate Professor, Pediatrics - Gastroenterology
BioI enjoy working with a multidisciplinary team to care for patients who have complex medical needs with the aim of giving children a better future. As a clinical researcher, my main focus is on finding improved therapies for autoimmune and cholestatic liver diseases, since an ideal therapy currently does not exist.
-
Burak Alsan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsPilot Study on the Use of Televisits for Transition Education for Young Adults with Chronic Disease
-
Emily Alsentzer
Assistant Professor of Biomedical Data Science, of Medicine (Biomedical Informatics Research) and, by courtesy, of Computer Science
BioDr. Emily Alsentzer is an Assistant Professor in Biomedical Data Science and, by courtesy, Computer Science at Stanford University. Her research leverages machine learning (ML) and natural language processing (NLP) to augment clinical decision-making and broaden access to high quality healthcare. She focuses on integrating medical expertise into ML models to ensure responsible deployment in clinical workflows. Dr. Alsentzer completed a postdoctoral fellowship at Brigham and Women’s Hospital where she worked to deploy ML models within the Mass General Brigham healthcare system. She received her PhD from the Health Sciences and Technology program at MIT and Harvard Medical School and holds degrees in computer science (BS) and biomedical informatics (MS) from Stanford University. She has served as General Chair for the Machine Learning for Health Symposium and founding organizer for SAIL and the Conference on Health, Inference, and Learning (CHIL).
-
Olivia Altamirano, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsCulturally Sensitive Therapy is a group psychotherapy for people with early psychosis and their families. Study aims are to understand if this treatment is compatible with this population, to assess improvements in family functioning and mental health symptoms, to assess mediating factors (e.g., increased usage of adaptive religious and other cultural beliefs/values), and to assess longevity of improvements. Last, we aim to qualitatively understand participants’ experiences with this treatment.
-
Nicolas Altemose
Assistant Professor of Genetics
Current Research and Scholarly InterestsThe Altemose Lab develops new experimental and analytical tools to study how chromatin proteins organize and regulate complex regions of the human genome.
-
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
